Matches in SemOpenAlex for { <https://semopenalex.org/work/W3196567413> ?p ?o ?g. }
- W3196567413 endingPage "703" @default.
- W3196567413 startingPage "691" @default.
- W3196567413 abstract "To evaluate the role of oral anticoagulation in patients with stage 5 chronic kidney disease (CKD-5) or end-stage kidney disease (ESKD).A literature search of PubMed (January 2000 to July 1, 2021), the Cochrane Library, and Google Scholar databases (through April 1, 2021) was performed with keywords DOAC (direct-acting oral anticoagulant) OR NOAC or dabigatran OR rivaroxaban OR apixaban OR edoxaban AND end-stage kidney disease combined with atrial fibrillation (AF) or venous thromboembolism (VTE) OR pulmonary embolism OR deep-vein thrombosis.Case-control, cohort, and randomized controlled trials comparing DOACs to an active control for AF or VTE in patients with CKD-5 or ESKD and reporting outcomes of stroke, recurrent thromboembolism, or major bleeding were included.Nine studies were included. Efficacy data supporting routine use of warfarin or DOACs in CKD-5 or ESKD are limited. Rivaroxaban and apixaban may provide enhanced safety compared to warfarin in patients with AF. Data for VTE are limited to 1 retrospective study.Because of the paucity of rigorous, prospective studies in CKD-5 or ESKD, OACs should not be broadly used in this population. It is clear that data regarding efficacy of DOACs cannot be reliably and safely extrapolated from the non-ESKD population. Therefore, use of OACs in this population should be individualized.If OACs for stroke prevention with AF are deemed necessary, apixaban or rivaroxaban can be considered. DOACs cannot currently be recommended over warfarin in patients with CKD-5 or ESKD and VTE." @default.
- W3196567413 created "2021-09-13" @default.
- W3196567413 creator A5009746756 @default.
- W3196567413 creator A5055396521 @default.
- W3196567413 creator A5060893585 @default.
- W3196567413 creator A5062909961 @default.
- W3196567413 date "2021-08-29" @default.
- W3196567413 modified "2023-09-29" @default.
- W3196567413 title "A Review of Direct Oral Anticoagulants in Patients With Stage 5 or End-Stage Kidney Disease" @default.
- W3196567413 cites W1913544684 @default.
- W3196567413 cites W1989090496 @default.
- W3196567413 cites W2050178600 @default.
- W3196567413 cites W2050636770 @default.
- W3196567413 cites W2052233064 @default.
- W3196567413 cites W2073789348 @default.
- W3196567413 cites W2115198007 @default.
- W3196567413 cites W2121407434 @default.
- W3196567413 cites W2141768943 @default.
- W3196567413 cites W2142970733 @default.
- W3196567413 cites W2152412672 @default.
- W3196567413 cites W2161038071 @default.
- W3196567413 cites W2162586165 @default.
- W3196567413 cites W2166551141 @default.
- W3196567413 cites W2216123836 @default.
- W3196567413 cites W2225937646 @default.
- W3196567413 cites W2308344547 @default.
- W3196567413 cites W2337007159 @default.
- W3196567413 cites W2442448576 @default.
- W3196567413 cites W2528808870 @default.
- W3196567413 cites W2534290193 @default.
- W3196567413 cites W2581569447 @default.
- W3196567413 cites W2588182624 @default.
- W3196567413 cites W2589662789 @default.
- W3196567413 cites W2596305759 @default.
- W3196567413 cites W2623061081 @default.
- W3196567413 cites W2735710351 @default.
- W3196567413 cites W2757693118 @default.
- W3196567413 cites W2790801037 @default.
- W3196567413 cites W2792857103 @default.
- W3196567413 cites W2888082174 @default.
- W3196567413 cites W2888931236 @default.
- W3196567413 cites W2897495391 @default.
- W3196567413 cites W2906748943 @default.
- W3196567413 cites W2957544571 @default.
- W3196567413 cites W2987040875 @default.
- W3196567413 cites W2997217735 @default.
- W3196567413 cites W3000331099 @default.
- W3196567413 cites W3004050106 @default.
- W3196567413 cites W3014494431 @default.
- W3196567413 cites W3098526172 @default.
- W3196567413 cites W3126268935 @default.
- W3196567413 cites W3139113952 @default.
- W3196567413 cites W3151379724 @default.
- W3196567413 cites W4240996941 @default.
- W3196567413 doi "https://doi.org/10.1177/10600280211040093" @default.
- W3196567413 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34459281" @default.
- W3196567413 hasPublicationYear "2021" @default.
- W3196567413 type Work @default.
- W3196567413 sameAs 3196567413 @default.
- W3196567413 citedByCount "6" @default.
- W3196567413 countsByYear W31965674132022 @default.
- W3196567413 countsByYear W31965674132023 @default.
- W3196567413 crossrefType "journal-article" @default.
- W3196567413 hasAuthorship W3196567413A5009746756 @default.
- W3196567413 hasAuthorship W3196567413A5055396521 @default.
- W3196567413 hasAuthorship W3196567413A5060893585 @default.
- W3196567413 hasAuthorship W3196567413A5062909961 @default.
- W3196567413 hasConcept C126322002 @default.
- W3196567413 hasConcept C127413603 @default.
- W3196567413 hasConcept C177713679 @default.
- W3196567413 hasConcept C2776301958 @default.
- W3196567413 hasConcept C2778653478 @default.
- W3196567413 hasConcept C2778661090 @default.
- W3196567413 hasConcept C2778810321 @default.
- W3196567413 hasConcept C2779134260 @default.
- W3196567413 hasConcept C2779161974 @default.
- W3196567413 hasConcept C2780290652 @default.
- W3196567413 hasConcept C2780638905 @default.
- W3196567413 hasConcept C2780645631 @default.
- W3196567413 hasConcept C2908647359 @default.
- W3196567413 hasConcept C3019040382 @default.
- W3196567413 hasConcept C71924100 @default.
- W3196567413 hasConcept C78519656 @default.
- W3196567413 hasConcept C99454951 @default.
- W3196567413 hasConceptScore W3196567413C126322002 @default.
- W3196567413 hasConceptScore W3196567413C127413603 @default.
- W3196567413 hasConceptScore W3196567413C177713679 @default.
- W3196567413 hasConceptScore W3196567413C2776301958 @default.
- W3196567413 hasConceptScore W3196567413C2778653478 @default.
- W3196567413 hasConceptScore W3196567413C2778661090 @default.
- W3196567413 hasConceptScore W3196567413C2778810321 @default.
- W3196567413 hasConceptScore W3196567413C2779134260 @default.
- W3196567413 hasConceptScore W3196567413C2779161974 @default.
- W3196567413 hasConceptScore W3196567413C2780290652 @default.
- W3196567413 hasConceptScore W3196567413C2780638905 @default.
- W3196567413 hasConceptScore W3196567413C2780645631 @default.
- W3196567413 hasConceptScore W3196567413C2908647359 @default.
- W3196567413 hasConceptScore W3196567413C3019040382 @default.